Sarepta Therapeutics Management
Management criteria checks 4/4
Sarepta Therapeutics' CEO is Doug Ingram, appointed in Jun 2017, has a tenure of 6.83 years. total yearly compensation is $1.66M, comprised of 48.1% salary and 51.9% bonuses, including company stock and options. directly owns 0.41% of the company’s shares, worth R$257.14M. The average tenure of the management team and the board of directors is 3.3 years and 7.9 years respectively.
Key information
Doug Ingram
Chief executive officer
US$1.7m
Total compensation
CEO salary percentage | 48.1% |
CEO tenure | 6.8yrs |
CEO ownership | 0.4% |
Management average tenure | 3.3yrs |
Board average tenure | 7.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$2m | US$800k | -US$536m |
Sep 30 2023 | n/a | n/a | -US$691m |
Jun 30 2023 | n/a | n/a | -US$908m |
Mar 31 2023 | n/a | n/a | -US$1b |
Dec 31 2022 | US$125m | US$740k | -US$703m |
Sep 30 2022 | n/a | n/a | -US$716m |
Jun 30 2022 | n/a | n/a | -US$507m |
Mar 31 2022 | n/a | n/a | -US$357m |
Dec 31 2021 | US$2m | US$730k | -US$419m |
Sep 30 2021 | n/a | n/a | -US$486m |
Jun 30 2021 | n/a | n/a | -US$634m |
Mar 31 2021 | n/a | n/a | -US$704m |
Dec 31 2020 | US$1m | US$669k | -US$554m |
Sep 30 2020 | n/a | n/a | -US$601m |
Jun 30 2020 | n/a | n/a | -US$530m |
Mar 31 2020 | n/a | n/a | -US$656m |
Dec 31 2019 | US$1m | US$650k | -US$715m |
Sep 30 2019 | n/a | n/a | -US$620m |
Jun 30 2019 | n/a | n/a | -US$570m |
Mar 31 2019 | n/a | n/a | -US$403m |
Dec 31 2018 | US$1m | US$650k | -US$362m |
Sep 30 2018 | n/a | n/a | -US$245m |
Jun 30 2018 | n/a | n/a | -US$216m |
Mar 31 2018 | n/a | n/a | -US$170m |
Dec 31 2017 | US$57m | US$338k | -US$51m |
Compensation vs Market: Doug's total compensation ($USD1.66M) is below average for companies of similar size in the BR market ($USD5.98M).
Compensation vs Earnings: Doug's compensation has been consistent with company performance over the past year.
CEO
Doug Ingram (60 yo)
6.8yrs
Tenure
US$1,661,338
Compensation
Mr. Douglas S. Ingram, also known as Doug, J.D., Esq., has been Chief Executive Officer and President of Sarepta Therapeutics, Inc. since June 26, 2017. Mr. Ingram serves as an Independent Director of Rela...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 6.8yrs | US$1.66m | 0.41% $ 257.1m | |
Executive VP & CFO | 3.3yrs | US$3.71m | 0.038% $ 23.8m | |
Executive VP & Chief Technical Operations Officer | 1.3yrs | US$3.52m | 0.027% $ 16.6m | |
Executive VP | 3.3yrs | US$3.72m | 0.072% $ 44.8m | |
Executive VP | 3.3yrs | US$3.58m | 0.030% $ 18.9m | |
Executive Director of Investor Relations and Corporate Communications | no data | no data | no data | |
Executive VP & Chief People Officer | 2.5yrs | no data | no data | |
Executive VP and Chief of Global Policy & Advocacy Officer | 4.6yrs | no data | no data | |
Executive VP & Chief Customer Officer | 3.3yrs | no data | no data | |
Senior VP | 1.3yrs | no data | no data | |
Controller & VP | 7.1yrs | US$911.89k | no data | |
Senior Manager of Investor Relations | no data | no data | no data |
3.3yrs
Average Tenure
49yo
Average Age
Experienced Management: S1RP34's management team is considered experienced (3.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 6.8yrs | US$1.66m | 0.41% $ 257.1m | |
Independent Chairwoman | 15.1yrs | US$594.99k | 0.19% $ 120.9m | |
Chairman of Corporate Strategy Board & Independent Non-Employee Director | 13.8yrs | US$546.99k | 0.022% $ 13.8m | |
Independent Director | 8.8yrs | US$563.65k | 3.36% $ 2.1b | |
Member of Strategic & Scientific Advisory Board | 8.7yrs | no data | no data | |
Member of Scientific Advisory Board | 4.4yrs | no data | no data | |
Member of Strategic & Scientific Advisory Board | 8.7yrs | no data | no data | |
Independent Non-Employee Director | 8.8yrs | US$553.34k | 0.016% $ 9.8m | |
Member of Strategic & Scientific Advisory Board | 7.1yrs | no data | no data | |
Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
Member of Strategic & Scientific Advisory Board | 7.1yrs | no data | no data | |
Member of Scientific Advisory Board | 4.4yrs | no data | no data |
7.9yrs
Average Tenure
70yo
Average Age
Experienced Board: S1RP34's board of directors are considered experienced (7.9 years average tenure).